In: Vaccines, 2019, vol. 7, no. 4, p. 208
Highly attenuated poxviral vectors, such as modified vaccinia virus ankara (MVA), are promising vaccine candidates against several infectious diseases. One of the approaches developed to enhance the immunogenicity of poxvirus vectors is increasing the promoter strength and accelerating during infection production levels of heterologous antigens. Here, we have generated and characterized the ...
|
In: Acta Physiologiae Plantarum, 2010, vol. 32, no. 6, p. 1073-1084
|
In: Molecular Genetics and Genomics, 2010, vol. 284, no. 1, p. 25-32
|
In: The Journal of Membrane Biology, 2012, vol. 245, no. 5-6, p. 263-273
|
In: FEMS Microbiology Letters, 2004, vol. 232, no. 2, p. 173-179
|